Wednesday, December 23, 2009

Patients who have undergone sympathectomy are not suitable controls. Why?

Again, patients admitted with any malignancy, cholecys- tectomy, thyroidectomy, renal disease, cardiac disease, sympathectomy, or vascular graft were eliminated as controls.

This article reviews the evidence that neuroleptics may increase the risk of breast cancer via their effects on prolactin secretion.

Paul M. Schyve; Francine Smithline; Herbert Y. Meltzer
Neuroleptic-induced Prolactin Level Elevation and Breast Cancer: An Emerging Clinical Issue
Arch Gen Psychiatry, Nov 1978; 35: 1291 - 1301.